1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age who had symptoms before 13 years ID6484

Awaiting development [GID-TA11610] Expected publication date: TBC

  • Project information
  • Project documents

15025-Doxecitine-and-Doxribtimine-for-Thymidine-Kinase-2-Deficiency-V1.0-MAY24-NON-CONF.pdf (nihr.ac.uk)